Skip to main content

Persistent Asset Partners Ltd

SEC CIK
0002056052
Latest filing
Aug 6, 2026

CTNM holding history

Contineum Therapeutics, Inc. in every 13F filed by Persistent Asset Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTNM overviewAll 13F holders of CTNMFull Q2 2026 holdings

Shares (Q2 2026)
33,037
Value
$541.5K
% of portfolio
0.2%
Quarters held
2
Since Q4 2025
Holdings of CTNM by Persistent Asset Partners Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,037$541.5K0.2%+33,037NewHolders
Q1 20260$00.0%−13,853−100.0%Sold outHolders
Q4 202513,853$158.3K0.1%+13,853NewHolders